2020 annual financial data
China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares 2020 Operating margin
China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares 2020 operating margin…
Direct answer
Operating margin was -25.98%.
Operating income was -1,341,117 USD and net income was -10,287,872 USD.
Operating cash flow was 934,247 USD.
Get free China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,162,268 USD
- Operating income
- -1,341,117 USD
- Net income
- -10,287,872 USD
- Operating cash flow
- 934,247 USD
Explore related company data
View all 2020 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares financial years